Sort   by:  
 Page size 
UnknownA phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus.
Not available
S-EPMC10763622 | biostudies-literature
UnknownSafety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials.
Not available
S-EPMC10134004 | biostudies-literature
UnknownPredictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19.
Not available
S-EPMC9709705 | biostudies-literature
UnknownRapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy.
Not available
S-EPMC12449731 | biostudies-literature
UnknownPublisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
Not available
S-EPMC9851732 | biostudies-literature
UnknownAntiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
Not available
S-EPMC9395368 | biostudies-literature
UnknownEstimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.
Not available
S-EPMC2938354 | biostudies-literature
UnknownImmune Status and SARS-CoV-2 Viral Dynamics.
Not available
S-EPMC10469582 | biostudies-literature
UnknownAssociation Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
Not available
S-EPMC10469105 | biostudies-literature
UnknownOne Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 Trial.
Not available
S-EPMC10552586 | biostudies-literature
Sort   by:  
 Page size